James Galloway

12.8k total citations · 4 hit papers
278 papers, 5.5k citations indexed

About

James Galloway is a scholar working on Rheumatology, Hematology and Epidemiology. According to data from OpenAlex, James Galloway has authored 278 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Rheumatology, 48 papers in Hematology and 42 papers in Epidemiology. Recurrent topics in James Galloway's work include Rheumatoid Arthritis Research and Therapies (133 papers), Systemic Lupus Erythematosus Research (52 papers) and Autoimmune and Inflammatory Disorders Research (41 papers). James Galloway is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (133 papers), Systemic Lupus Erythematosus Research (52 papers) and Autoimmune and Inflammatory Disorders Research (41 papers). James Galloway collaborates with scholars based in United Kingdom, United States and Italy. James Galloway's co-authors include Kimme L Hyrich, Deborah Symmons, Mark Lunt, Kath Watson, William G Dixon, Andrew Ustianowski, Katie Bechman, Sam Norton, Sujith Subesinghe and Louise Mercer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

James Galloway

238 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

2009 532 citations Kimme L Hyrich, James Galloway et al. Annals of the Rheumatic Diseases profile →
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

2010 496 citations James Galloway, Kimme L Hyrich et al. Lara D. Veeken profile →
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications

2023 75 citations Mark Russell, Edward Alveyn et al. Annals of the Rheumatic Diseases profile →
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician

2024 58 citations Maya H Buch, James Galloway et al. profile →

Peers

Countries citing papers authored by James Galloway

Since Specialization

Citations

This map shows the geographic impact of James Galloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Galloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Galloway more than expected).

Fields of papers citing papers by James Galloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Galloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Galloway. The network helps show where James Galloway may publish in the future.

Co-authorship network of co-authors of James Galloway

This figure shows the co-authorship network connecting the top 25 collaborators of James Galloway. A scholar is included among the top collaborators of James Galloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Galloway. James Galloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of health literacy with disease outcomes in inflammatory arthritis: a systematic review 2025 ·Annals of the Rheumatic Diseases ·Mrinalini Dey, Shyam Sundar Budhathoki, (unknown), Sofía Ramiro, Kaleb Michaud, Sam Norton, Maya H Buch, Andrew P. Cope, Richard H. Osborne, James Galloway, Elena Nikiphorou	0
2	POS0867 INFLIXIMAB THERAPY FOR MULTISYSTEM SARCOIDOSIS: A SINGLE CENTRE EXPERIENCE 2024 ·Annals of the Rheumatic Diseases ·Deepak Nagra, Katie Bechman, (unknown), C.I. Baldwin, Edward Alveyn, Maryam Adas, (unknown), (unknown), (unknown), Mark Russell, James Galloway	0
3	P065 Patient-initiated follow up in rheumatoid arthritis: a systematic review and meta-analysis 2024 ·Lara D. Veeken ·Edward Alveyn, (unknown), Mark Perry, Sam Norton, James Galloway	0
4	The relationship between Zoster serology, vaccination uptake and infection rates: a single-centre cross-sectional study 2024 ·Rheumatology Advances in Practice ·(unknown), (unknown), (unknown), (unknown), (unknown), James Galloway	1
5	Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach 2024 ·Rheumatology Advances in Practice ·(unknown), (unknown), Edward Alveyn, Sarah Gallagher, Elizabeth Price, Mark Russell, Katie Bechman, Sam Norton, James Galloway	2
6	Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study 2024 ·RMD Open ·N. R. Stoll, Mrinalini Dey, Sam Norton, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew P. Cope, Heidi Lempp, James Galloway, Elena Nikiphorou	7
7	The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19 2024 ·Journal of Infection ·Katie Bechman, Amelia Green, Mark Russell, (unknown), Bang Zheng, Sam Norton, Rebecca Smith, Amir Mehrkar, (unknown), Ben Goldacre, Brian MacKenna, James Galloway	1
8	Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis 2024 ·RMD Open ·(unknown), (unknown), Toby Garrood, (unknown), (unknown), James Galloway, Sam Norton, Bruce Kirkham	6
9	E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study 2024 ·Lara D. Veeken ·(unknown), (unknown), (unknown), (unknown), Jon Packham, James Galloway, Jonathan Hill, Sara Müller, Samantha Hider, Zoé Paskins, Laurna Bullock, Ian C. Scott	1
10	No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort 2024 ·Vaccines ·Deepak Nagra, Katie Bechman, Mark Russell, (unknown), Maryam Adas, Sujith Subesinghe, Andrew I Rutherford, Edward Alveyn, Samir Patel, Chris Wincup, Arti Mahto, (unknown), (unknown), Andrew P. Cope, Sam Norton, James Galloway	1
11	Impact of visualising healthcare quality performance: a systematic review 2024 ·BMJ Open ·(unknown), Edward Alveyn, Mrinalini Dey, (unknown), Mark Russell, Sam Norton, James Galloway	0
12	The HAVEN study—hydroxychloroquine in ANCA vasculitis evaluation—a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan 2023 ·Trials ·(unknown), Lauren D. Arnold, Fiona Reid, (unknown), Alina Casian, Shirish Sangle, N S Morton, Louise Nel, (unknown), Susan John, Sangmi Kim, (unknown), Raashid Luqmani, David Jayne, James Galloway, Abdel Douiri, David D’Cruz, (unknown)	2
13	OA14 The role of anifrolumab in treating life threatening systemic lupus erythematosus with severe mucocutaneous involvement 2023 ·Rheumatology Advances in Practice ·(unknown), (unknown), Deepak Nagra, Jennifer Hannah, Patrick Gordon, James Galloway, Chris Wincup	1
14	Online Patient-Reported Outcome Measure Engagement Is Dependent on Demographics and Locality: Findings From an Observational Cohort 2023 ·The Journal of Rheumatology ·Mark Yates, Katie Bechman, Maryam Adas, (unknown), Mark Russell, Deepak Nagra, B. F. Clarke, Joanna Ledingham, Sam Norton, James Galloway	4
15	Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort 2023 ·Autoimmunity Reviews ·Fabiola Atzeni, Fabio Cacciapaglia, James Galloway, Andreina Manfredi, Garifallia Sakellariou, Sam Norton, Elisa Gremese, Francesca Romana Spinelli, Ombretta Viapiana, Matteo Piga, Gian Luca Erre, Elena Bartoloni	1
16	Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation 2022 ·Open Forum Infectious Diseases ·Michael Brown, (unknown), (unknown), Megan Plowright, Katie Drury, Joshua Gahir, (unknown), Tom Newman, Kate Adams, James Galloway, (unknown), (unknown), Tommy Rampling, Joby Cole, Nicholas Easom, Anna L. Goodman, Michael Marks	2
17	Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19 2021 ·Pulmonary Pharmacology & Therapeutics ·Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David Jayne, James Galloway, Frances Hall, Ian B. Wilkinson, Phil Ambery, Joseph Cheriyan	10
18	The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health 2018 ·Arthritis & Rheumatology ·Faith Matcham, James Galloway, Matthew Hotopf, Emmert Roberts, Ian C. Scott, Sophia Steer, Sam Norton	41
19	The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register 2018 ·Lara D. Veeken ·Faith Matcham, Rebecca Davies, Matthew Hotopf, Kimme L Hyrich, Sam Norton, Sophia Steer, James Galloway	82
20	The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey. 2017 ·PubMed ·Elena Nikiphorou, James Galloway, Piet L. C. M. van Riel, Yusuf Yazıcı, Glenn Haugeberg, Andrew J.K. Östör, Feride Göğüş, Markku Kauppi, Tuulikki Sokka	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact